Found: 9
Select item for more details and to access through your institution.
Impact of the COVID-19 pandemic on the volume of laboratory testing.
- Published in:
- Biochimica Clinica, 2023, v. 47, n. 2, p. 171, doi. 10.19186/BC_2023.015
- By:
- Publication type:
- Article
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test.
- Published in:
- Diagnosis (2194-802X), 2023, v. 10, n. 2, p. 187, doi. 10.1515/dx-2022-0138
- By:
- Publication type:
- Article
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
- Published in:
- Diagnosis (2194-802X), 2021, v. 8, n. 3, p. 322, doi. 10.1515/dx-2020-0154
- By:
- Publication type:
- Article
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 8, p. 1506, doi. 10.1515/cclm-2023-0181
- By:
- Publication type:
- Article
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2023, v. 61, n. 7, p. 1343, doi. 10.1515/cclm-2023-0055
- By:
- Publication type:
- Article
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 8, p. e181, doi. 10.1515/cclm-2022-0385
- By:
- Publication type:
- Article
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 6, p. 930, doi. 10.1515/cclm-2022-0212
- By:
- Publication type:
- Article
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters.
- Published in:
- 2022
- By:
- Publication type:
- Letter